Analysed CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) News Sources
ZEISS CLINIC 360 receives FDA 510k clearance, amplifying patient care through simplified clinical insights
19-08-2026
yahoo.com
Assessment of the Global Intraoperative Radiation Therapy Market 2026-2031, Featuring Profiles of Siemens Healthineers, Elekta, Carl Zeiss Meditec, IntraOp Medical, iCAD and More
07-09-2026
yahoo.com
Is Carl Zeiss Meditec (XTRA:AFX) Fairly Valued Ahead Of The German Corporate Conference?
23-09-2026
yahoo.com
From diagnosis to treatment, ZEISS introduces innovations across ZEISS Retina Workflow at EURETINA 2026
24-09-2026
yahoo.com
What is the current price of CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS)?
The current price of CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) is $35.
CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) since the previous trading day is $-3.21.
CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) since the previous trading day is -8.4009%.
What is the most recent average sentiment score for CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS)?
The most recent average sentiment score for CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS)?
The most recent sentiment for CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS) is .
SEC-8K** Filing Available For CARL ZEISS MEDITEC AG - BR (CZMWF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.